Ago Ahene

Ago Ahene has a diverse work experience spanning several companies in the biotechnology industry. Ago currently serves as the Head of Bioanalytics-CMC at Walking Fish Therapeutics, Inc., a position they started in December 2021. Before that, they held various roles at Five Prime Therapeutics, Inc., including Senior Director from August 2019 to February 2022 and Director of Bioanalytical Development from November 2015 to February 2022.

Prior to their time at Five Prime Therapeutics, Ago worked at XOMA as the Director of Bioanalytics and Pharmacokinetics from April 2011 to October 2015. In this role, they provided scientific and administrative direction to the Bioanalytical Development and Pharmacokinetics Groups, ensuring GLP compliance and preparing SOPs and test methods.

Before XOMA, Ago worked as a Consultant at Pharmargo LLC from January 2010 to July 2011. Additionally, they co-founded Biosimilar Partners in January 2010, where they focused on developing biosimilars and guiding their development through Phase 1 clinical trials.

Ago's career began at Roche Palo Alto in 1995, where they held the role of Associate Director from an unspecified start date to December 2009. Ago also worked at Syntex as a Staff Researcher II from January 1994 to an unspecified end date.

Overall, Ago Ahene's work experience showcases their expertise in bioanalytics, pharmacokinetics, and the development of biologics in the biotechnology industry.

From 1981 to 1988, Ago Ahene pursued their Doctor of Philosophy (Ph.D.) degree at The Johns Hopkins University. The field of study for their doctoral program is not specified.